0001181431-13-023457.txt : 20130425 0001181431-13-023457.hdr.sgml : 20130425 20130425165609 ACCESSION NUMBER: 0001181431-13-023457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130423 FILED AS OF DATE: 20130425 DATE AS OF CHANGE: 20130425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECH GROWTH N V CENTRAL INDEX KEY: 0001259869 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35726 FILM NUMBER: 13783564 MAIL ADDRESS: STREET 1: DE RUYTERKADE 62 WILLEMSTAD CITY: CURACO STATE: P8 ZIP: 000000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Radius Health, Inc. CENTRAL INDEX KEY: 0001428522 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 800145732 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ATTN: CHIEF FINANCIAL OFFICER STREET 2: 201 BROADWAY, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 425 9225 MAIL ADDRESS: STREET 1: ATTN: CHIEF FINANCIAL OFFICER STREET 2: 201 BROADWAY, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: MPM ACQUISITION CORP DATE OF NAME CHANGE: 20080228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35726 FILM NUMBER: 13783563 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 4 1 rrd377636.xml FORM 4 X0306 4 2013-04-23 0 0001428522 Radius Health, Inc. NONE 0001259869 BIOTECH GROWTH N V SNIPWEG 26 CURACAO 00000 0 0 1 0 0000924223 BB BIOTECH AG VORDERGASSE 3 SCHAFFHAUSEN V8 8200 SWITZERLAND 0 0 1 0 Series B Convertible Preferred Stock 2013-04-23 4 P 0 97688 61.42 A 2013-04-23 Common Stock 976880 97688 D Common Stock Warrant 6.142 2013-04-23 4 P 0 244220 A 2013-04-23 2018-04-23 Common Stock 244220 244220 D Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Radius Health, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V. Each share of the Series B Convertible Preferred Stock has no expiration date and is convertible at any time, in whole or in part, at the election of the holder at a conversion rate of 10 shares of Common Stock for every 1 share of Series B Convertible Preferred Stock. Payment of an aggregate purchase price equal to the product of (i) $61.42 multiplied by (ii) the total number of reported shares of Series B Convertible Preferred Stock entitled the purchaser to receive the reported shares of Series B Convertible Preferred Stock as well as the reported Warrant exercisable for shares of Common Stock. /s/ Pascal Schmucki Signatory Authority for Biotech Growth N.V. and BB Biotech AG 2013-04-25